Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
BMC Cancer. 2022 Jun 7;22(1):625. doi: 10.1186/s12885-022-09687-x.
BMC Cancer. 2022.
PMID: 35672677
Free PMC article.
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis.
Italiano A, Nanda S, Briggs A, Garcia-Foncillas J, Lassen U, Vassal G, Kummar S, van Tilburg CM, Hong DS, Laetsch TW, Keating K, Reeves JA, Fellous M, Childs BH, Drilon A, Hyman DM.
Italiano A, et al. Among authors: reeves ja.
Cancers (Basel). 2020 Nov 4;12(11):3246. doi: 10.3390/cancers12113246.
Cancers (Basel). 2020.
PMID: 33158040
Free PMC article.
Item in Clipboard
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
Bridgewater J, Jiao X, Parimi M, Flach C, Stratford J, Kamburov A, Schmitz AA, Zong J, Reeves JA, Keating K, Bruno A, Fellous M, Pereira MB, Bazhenova L.
Bridgewater J, et al. Among authors: reeves ja.
Cancer Treat Res Commun. 2022;33:100623. doi: 10.1016/j.ctarc.2022.100623. Epub 2022 Aug 23.
Cancer Treat Res Commun. 2022.
PMID: 36041373
Free article.
Item in Clipboard
Cite
Cite